Beijing Biostar Pharmaceuticals Co., Ltd.
16
5
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
25%
4 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Role: collaborator
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
Role: lead
Phase II Clinical Study of Utidelone Capsule (UTD2) in Patients With Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Role: lead
Utidelone Capsule Monotherapy for Patients with Advanced Solid Tumors
Role: lead
Utidelone Injection Combined with Bevacizumab Injection for Non-small Cell Lung Cancer Patients with Brain Metastases
Role: lead
Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer
Role: collaborator
Tolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors
Role: lead
Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Role: lead
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
Role: lead
Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Role: lead
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
Role: collaborator
Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
Role: collaborator
Clinical Study of Utidelone Injection in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）
Role: lead
PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
Role: lead
Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Colorectal Cancer
Role: lead
Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer
Role: lead
All 16 trials loaded